Our contact directory for GSK operations around the world. Privacy questions: Should you have any questions or concerns regarding privacy at GSK, please reach out to us using the contact information specific to your location, provided below.

At GSK, we unite science, technology and talent to get ahead of disease together

Learn more about GSK around the world by visiting our market websites listed out below. For contact information including product information websites for healthcare professionals, visit our Worldwide directory .

At GSK, we all have our own personal motivations for wanting to get ahead of disease. And together, by uniting cutting-edge science, advanced technology, and our incredibly talented people, we're working towards positively impacting the health of 2.5 billion people by the end of this decade - and we invite you to join us on this journey.

Browse GSK's global press release archive for media and investors. Search by keyword or browse by year/business category. Press releases issued by our local operating companies can be viewed on our market websites.

Jan 29, 2024 · GSK plc (LSE/NYSE: GSK) today announced the European Commission* granted marketing authorisation for Omjjara (momelotinib), a once-a-day, oral JAK1/JAK2 and activin A receptor type 1 (ACVR1) inhibitor.

Bienvenue chez GSK France. Nous sommes une entreprise biopharmaceutique de premier plan en France, en termes d’emploi et d’implantation, avec la mission d’unir la science, la technologie et les talents pour devancer ensemble la maladie.

Jun 7, 2023 · GSK plc (LSE/NYSE: GSK) today announced that the European Commission has authorised Arexvy (respiratory syncytial virus vaccine, adjuvanted) for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in adults 60 years of age and older. This is the first time an RSV vaccine ...

In GSK, la cultura aziendale è patrimonio di tutti noi. Si alimenta dalle piccole cose che ognuno di noi fa ogni giorno per aiutarci ad affrontare insieme le malattie. Guida la realizzazione della nostra strategia e rende GSK un luogo in cui le persone possono prosperare.

At GSK, we unite science, technology and talent to get ahead of disease together. We prevent and treat disease with specialty medicines, vaccines and general medicines investing in four core therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; infectious diseases.